Sign inJoin waitlistJoin the waitlist

Scott Lippman

Director, UCSD Moores Cancer Center · University of California (San Diego) Medical Center

Credentials: · ·

History

UCSD Moores Cancer Center · University of California (San Diego) Medical Center
Present
University of California (San Diego) Medical Center
Present

Medical Oncology
2014–2016
Pathology-Anatomic and Clinical
University of California (San Diego) Medical Center
2010–2014
Johns Hopkins Univ Sch of Med
1977–1981

Research

Lung cancer
Review · New England Journal of Medicine · 2008 · Last of 3 authors · 2,141 citations
The influence of finasteride on the development of prostate cancer
New England Journal of Medicine · 2003 · 1,974 citations
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter
New England Journal of Medicine · 2004 · 1,768 citations

WH
Waun Hong
174 papers
IT
Ian Thompson
44 papers · 15 as a resident
Razelle Kurzrock
41 papers
Adel El-Naggar
40 papers
EK
Edward Kim
35 papers · 1 as a fellow
Dong Shin
33 papers
FK
Fadlo Khuri
33 papers
GC
Gary Clayman
32 papers · 1 as a resident
BG
Bonnie Glisson
30 papers
HP
Howard Parnes
30 papers
AS
Anita Sabichi
26 papers
Shu Kato
26 papers

Grants

Mapping Immuno-Genomic Drivers of the Head and Neck Precancer Invasive-Disease Transition
National Cancer Institute · U01
PI · $3.1M · University of California, San Diego
2023–2028
Targeting Signaling Vulnerabilities for Oral Cancer Prevention
National Institute of Dental and Craniofacial Research · R01
PI · $4.7M · University of California, San Diego
2017–2027
Specialized Cancer Center Support Grant
National Cancer Institute · P30
Contact PI · $53.6M · University of California, San Diego
1996–2026
M D Anderson Cancer Center Head & Neck SPORE
National Cancer Institute · P50
Contact PI · $9.7M · University of Tx Md Anderson Can Ctr
2002–2015

Clinical trials

Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia
Principal investigator · Active not recruiting · Phase 2
University of Arizona
2023–2026
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2016–2026
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer
Study chair · Completed · Phase 2
National Cancer Institute (NCI)
2006–2008
S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT
Study chair · Terminated
SWOG Cancer Research Network
2005–2009